Voglibose 0.3 mg Australia

Description

Introduction

Voglibose 0.3 mg Australia contains voglibose 0.3 mg in tablet form. It is used in the management of type 2 diabetes, particularly when blood glucose rises after meals are a concern. Voglibose slows the digestion of certain carbohydrates in the small intestine. A healthcare professional can assess how it fits with other aspects of diabetes care.

What Is It?

Voglibose is an alpha-glucosidase inhibitor. This group of medicines acts on digestive enzymes rather than directly increasing insulin release. Each tablet contains 0.3 mg of voglibose as the active ingredient. The complete list of inactive ingredients should be checked on the supplied packaging, especially if an allergy or intolerance is a concern.

How Does It Work?

After a meal, enzymes in the small intestine break some carbohydrates down into sugars that can enter the bloodstream. Voglibose slows these enzymes, delaying carbohydrate digestion and sugar absorption. This can reduce the rise in blood glucose after eating.

Its main effect is on post-meal glucose. It does not replace nutrition measures, physical activity, glucose monitoring or other treatment that forms part of a diabetes care plan. Blood glucose results help a healthcare professional assess the response over time.

Common Uses

Voglibose is used for type 2 diabetes when better control of blood glucose after meals is needed. It may be used as part of a plan that also includes other diabetes medicines. The choice of treatment depends on glucose results, current medicines and other health conditions. Voglibose does not treat diabetic ketoacidosis or diabetic coma, both of which require urgent medical care.

Available Strengths

This family is available in 0.2 mg, 0.3 mg.

Key Features

• Active ingredient: voglibose.
• Strength: 0.3 mg per tablet.
• Dosage form: oral tablet.
• Acts in the intestine to slow the breakdown of certain carbohydrates.
• Addresses the rise in blood glucose that occurs after eating.
• Available in quantities of 30, 60 or 90 tablets; the supplied pack shows its exact contents.

Benefits

• Voglibose can lower blood glucose measured after meals in people with type 2 diabetes.
• Reducing post-meal glucose rises may contribute to overall glucose management when treatment is regularly reviewed.
• Its effect on carbohydrate digestion gives healthcare professionals another option when post-meal glucose remains a concern.
• Individual results vary, and glucose measurements are needed to assess the effect.

Possible Side Effects

Digestive effects are among the more commonly reported unwanted effects. Some symptoms settle, while others need review by a healthcare professional.

• Wind, bloating or a feeling of fullness in the abdomen.
• Abdominal discomfort, loose stools or diarrhoea.
• Constipation, nausea, vomiting or reduced appetite.
• Low blood glucose, particularly when voglibose is taken with insulin or medicines that increase insulin release.
• Rare bowel obstruction-like symptoms, including marked abdominal swelling and pain, which need prompt assessment.
• Rare serious liver problems. Yellowing of the skin or eyes, especially with feeling unwell or loss of appetite, needs prompt medical assessment.

Precautions

• Tell a healthcare professional about any previous allergic reaction to voglibose or an ingredient in the tablet.
• Discuss a history of bowel obstruction, abdominal surgery or intestinal disease that affects digestion or absorption.
• Disclose liver or kidney disease, as these conditions may affect diabetes management and monitoring.
• Serious infection, injury or surgery may require a review of the usual diabetes treatment plan.
• Pregnancy, plans for pregnancy and breastfeeding call for product-specific advice from a healthcare professional.
• Ask a healthcare professional about use in children; guidance for this product should come from its supplied information.

Additional Precautions

• Regular blood glucose review can show whether post-meal glucose is responding as intended.
• Symptoms of low blood glucose can include sweating, hunger, trembling and weakness. A healthcare professional can explain when to seek help.
• Voglibose slows the breakdown of table sugar. Glucose is used to treat low blood glucose associated with voglibose; an individual response plan should be confirmed with a healthcare professional.
• Persistent diarrhoea, severe bloating or worsening abdominal pain needs medical review.
• A pharmacist can check the supplied pack for the complete ingredient list if an allergy is a concern.

Storage Instructions

• Follow the storage directions and expiry date printed on the supplied packaging.
• Keep the tablets protected from direct sunlight, excessive heat and moisture.
• Keep all medicines out of the reach of children.
• Ask a pharmacist about disposing of expired or unwanted tablets.

How to Take

• Follow the directions provided by the prescribing healthcare professional and on the supplied label.
• Voglibose acts on carbohydrate digestion around meals. A pharmacist or prescriber can confirm the timing for this product.
• Use the tablet as directed for the supplied formulation. Ask a pharmacist before crushing, dispersing or otherwise changing it.
• If a dose is missed, follow the supplied instructions or ask a pharmacist. Do not take an extra tablet to make up for a missed dose unless directed.
• Do not change the treatment schedule without discussing it with a healthcare professional.

Drug Interactions

• Insulin may increase the risk of low blood glucose when used with voglibose.
• Sulfonylureas and other medicines that increase insulin release can also increase that risk.
• Other medicines may affect blood glucose control and the monitoring needed during diabetes treatment.
• Tell a pharmacist or prescriber about all prescription medicines, over-the-counter products and supplements so the full combination can be checked.

Why Choose This Product?

• It provides voglibose in a 0.3 mg oral tablet when this ingredient and strength form part of a prescribed plan.
• Voglibose addresses post-meal blood glucose rises through its effect on carbohydrate digestion.
• The tablet can be incorporated into a treatment plan that is assessed with blood glucose monitoring.
• The supplied packaging provides the details needed to check ingredients, storage and directions for the exact tablets received.

Frequently Asked Questions (FAQs)

What is the active ingredient?

Each tablet contains 0.3 mg of voglibose as the active ingredient.

What form does this product come in?

It comes as an oral tablet. Follow the supplied label for directions specific to the tablets received.

What is voglibose used for?

It is used in the management of type 2 diabetes, particularly when blood glucose after meals is a concern.

How does it affect blood glucose?

It slows the digestion of certain carbohydrates, which can lessen the rise in blood glucose after eating.

Does it replace other diabetes care?

No. Nutrition, physical activity, glucose monitoring and other medicines may remain part of a treatment plan.

Can it be combined with other diabetes medicines?

It may be used with other medicines when a healthcare professional considers the combination appropriate. Monitoring may need to change.

Can it cause low blood glucose?

Low blood glucose can occur, especially when voglibose is combined with insulin or a sulfonylurea.

What digestive effects may occur?

Wind, bloating, abdominal discomfort and changes in bowel movements may occur. Persistent or severe symptoms need medical review.

What should someone with an allergy check?

A pharmacist can check the complete ingredient list on the supplied pack.

How should the tablets be stored?

Follow the storage directions on the supplied packaging and keep the tablets out of the reach of children.

Related Products

• Voglibose 0.2 mg Australia
• Voglibose 0.3 mg Australia
• Glimepiride 4 mg Australia
• Repaglinide 1 mg Australia
• Acarbose 50 mg Australia
• Bromocriptine 1.25 mg Australia